INTRODUCTION
Members of the Src family of nonreceptor protein tyrosine kinases function in multiple key cellular processes, including apoptosis, growth, differentiation, adhesion, gene transcription, and others (reviewed in ref. [1] ). Dysregulated Src family kinase activity and expression can lead to tumorigenesis [2, 3] . The Src family member, Lyn, is expressed widely in hematopoietic cells, and studies in Lyn Ϫ/Ϫ mice have revealed positive and negative roles for Lyn in cell proliferation, differentiation, and receptor-mediated signaling. The B-lymphoid phenotype is especially altered by the deletion of Lyn. Lyn Ϫ/Ϫ mice typically have reduced numbers of recirculating, mature B cells in the periphery, increased numbers of immunoglobulin (Ig)M-producing plasma cells in the tissues, and high levels of serum IgM and of circulating, autoreactive antibodies [4 -6] . In vitro, Lyn-deficient B-lymphocytes are hyper-responsive to anti-IgM-induced proliferation, linked in part to defective, negative regulation of B cell receptor signaling [4] . Lyn Ϫ/Ϫ macrophages are similarly hyper-responsive to colony stimulating factor (CSF)-1 and granulocyte macrophage-CSF-induced proliferation in vitro, and Lyn Ϫ/Ϫ mice have increased numbers of splenic macrophages and neutrophils as well as an increased incidence of monocyte/macrophage tumors in vivo [3] .
Mast cell (MC) differentiation and proliferation are regulated by cytokines, principally interleukin-3 (IL-3) [7] and the c-kit ligand, stem cell factor (SCF) [8] . The murine IL-3 receptor (IL-3R) is composed of an ␣-subunit and a ␤c-chain subunit, which are phosphorylated on tyrosine residues upon ligand stimulation (reviewed in ref. [9] ). IL-3 binding leads to phosphorylation of ␤c, the activation of the Janus family of protein kinase (JAK)2/signal transducer and activator of transcription (STAT)5, phosphatidylinositol-3 kinase (PI-3K), and Ras mitogen-activated protein kinase (MAPK) signaling pathways and to cell proliferation, survival, and differentiation. Similarly, the binding of SCF to the receptor tyrosine kinase, c-kit, stimulates protein phosphorylation and cell proliferation, survival, and differentiation.
It has been reported that Lyn deletion has no effect on [5, 10, 11] or reduces [12] the IL-3 and SCF-mediated proliferation and differentiation of mouse bone marrow-derived MC (BMMC) precursors in vitro and the numbers of mature MC in vivo. We were thus surprised to discover that Lyn-deficient mice have more peritoneal MC than wild-type (WT) mice. This observation led us to re-examine the role of Lyn in MC growth, death, and signaling pathways. We report that Lyn Ϫ/Ϫ BMMC divide faster in response to IL-3 and SCF during the 4 -5 weeks required to produce a Ͼ95% pure population of granular, receptor with high affinity for IgE (FcεRI)-positive BMMC. Furthermore, differentiated Lyn Ϫ/Ϫ BMMC continue to proliferate more rapidly than WT BMMC in cytokine-containing media, and they undergo less apoptosis when cytokines are removed. Additionally, Lyn Ϫ/Ϫ BMMC support greater phos-phorylation of the prosurvival kinase, Akt, and the proliferative kinase, extracellular-regulated kinase (ERK)1/2, when stimulated with IL-3. Thus, Lyn behaves as a negative regulator of murine MC survival and proliferation.
MATERIALS AND METHODS

Antibodies and growth factors
Monoclonal mouse antidinitrophenyl (anti-DNP) IgE was purified from ascites as described by Liu et al. [13] . Biotinylated anti-DNP IgE was prepared using EZ-Link Sulfo-NHS-Biotin (Pierce, Rockford, IL). Biotinylated anti-CD117 (c-kit) monoclonal antibody (mAb) and the isotype-control biotinylated rat anti-mouse IgG2B were purchased from Caltag (Burlingame, CA). Biotinylated anti-IL-3R␣ chain mAb antibody and isotype-control biotinylated rat antimouse IgG2a were from PharMingen (San Diego, CA 
Cells and cell culture conditions
WT and Lyn knockout mice [4] of the same background strain (C57BL6) were bred in specific, pathogen-free facilities in the University of New Mexico Animal Research Facility (Albuquerque, NM). BMMC were obtained by culturing BM from 8-to 12-week-old C57BL6 WT and Lyn Ϫ/Ϫ mice. Briefly, mice were killed, and BM were flushed from the femurs and tibias. The cells were cultured at a starting density of 0.5 ϫ 10 6 cells/ml at 37°C in a humidified atmosphere containing 5% CO 2 in RPMI-1640 medium, supplemented with 2 mM L-glutamine, 0.1 mM nonessential amino acids, 1 mM sodium pyruvate, 100 U/ml penicillin, 100 g/ml streptomycin, 10% fetal calf serum (FCS; Hyclone Laboratories Inc., Logan, UT), 55 M ␤-2-mercaptoethanol (2-ME), 1 mM HEPES (complete RPMI medium), and 30% WEHI-3-conditioned medium, as a source of IL-3 [14] . All cell-culture reagents were purchased from Life Technologies (Grand Island, NY). The nonadherent cells from the BM cultures were transferred every 7 days into fresh IL-3-containing medium. Cell cultures were maintained for 5-8 weeks, and toluidine blue staining identified MC. For in vitro growth curves, 8 ϫ 10 6 BM cells per plate were cultured in complete RPMI with 30% WEHI-3-conditioned RPMI medium or in RPMI medium supplemented with combinations of various growth factors (increasing amounts of IL-3 or 10 ng/ml IL-3 plus 20 ng/ml SCF). Each culture was performed in duplicate using cells plated at identical densities (5ϫ10 5 cells/ ml). Weekly cell counts were recorded by exclusion of trypan blue. By 5 weeks, essentially 100% of cells contained the prominent granules characteristic of differentiated MC. The experiments described below were all performed with 5-to 8-week-old MC cultures.
Isolation and staining of mouse peritoneal MC
Killed mice were injected intraperitoneally with 1-2 ml Hanks' buffer without calcium and magnesium. The cavity was gently massaged, and the peritoneal fluid was aspirated and placed on ice. Cells were centrifuged at 1000 rpm and washed twice with Hanks' medium. A portion of the cells was fixed and stained using methanol and 0.06% toluidine blue at a ratio of 1:1:1 (cells:methanol: 0.06% toluidine blue) for 5 min. Total cells (excluding occasional erythrocytes) and total MC (recognized by their characteristic toluidine blue-stained granules) were counted with a hemacytometer.
Analysis of c-kit, IL-3, and FcRI expression c-Kit receptor and IL-3R densities were measured by incubating BMMC with 1 g/ml biotinylated rat anti-mouse CD117 (c-kit) antibody or with 1 g/ml biotinylated rat anti-mouse IL-3R␣ chain antibody for 1 h at 4°C. Control cells were incubated with the isotype controls, 1 g/ml biotinylated rat IgG2b, or 1 g/ml biotinylated rat IgG2a for 1 h at 4°C. For IgE receptor density analysis, cells were incubated overnight with 1 g/ml biotinylated anti-DNP IgE at 37°C. Cells were washed twice with phosphate-buffered saline (PBS) and reincubated with biotinylated anti-DNP IgE for 1 h at 4°C. All cells were washed twice with PBS and incubated with avidin-R-phycoerythrin (A-PE; Molecular Probes, Inc., Eugene, OR; 1:200) for 1 h at 4°C. As a control, cells that were not pretreated with IgE were stained with A-PE. Fluorescence was analyzed by flow cytometry using a FACScan (Becton Dickinson, San Jose, CA).
Proliferation assays
BMMC were harvested, washed, and suspended in fresh medium with the original additives in the presence or absence of serum. The cells were divided into four equal portions and incubated for 24 or 48 h at 37°C in 5% CO 2 Cell-cycle analysis BMMC were harvested, washed, starved of growth factors and serum for 4 h, and cultured in the presence or absence of different growth factors at 5 ϫ 10 5 cells/ml in complete RPMI for 24 or 48 h. Cells were harvested again and washed twice in PBS. Cell-cycle analysis was performed by staining with 1 ml Krishan buffer [15] consisting of 0.1% sodium citrate, 0.3% (v/v) Nonidet P-40, 50 g/ml propidium iodide (PI; Sigma Chemical Co., St. Louis, MO), and 25 g/ml RNase A (Clontech, Palo Alto, CA), pH 7.4, at 4°C for 1 h. Cells were washed twice with PBS and resuspended in 0.5 ml Krishan buffer. Cell-cycle distribution was analyzed using a FACScan flow cytometer. The percentages of cells in G0 ϩ G1, S, and G2 ϩ M were calculated using Modfit software (Verity Software House, Topchan, ME).
Assays for caspase activity
Total caspase activity was measured with a CaspaTag Caspase activity kit (Intergen, Purchase, NY) according to the protocol supplied by the manufacturer. Briefly, BMMC were washed with RPMI medium and resuspended at 10 6 cells per ml in the absence or presence of various growth factors (RPMI medium supplemented with 30% WEHI-3-conditioned medium; 20 ng/ml SCF; 10 ng/ml IL-3; or 10 ng/ml IL-3 plus 20 ng/ml SCF). Samples were incubated with the carboxyfluorescein-labeled fluoromethyl ketone caspasespecific inhibitor (FAM-VAD-FMK) in a 5% CO 2 incubator at 37°C for 60 min. The cells were washed, stained with PI, and analyzed by two-color flow cytometry using a FACScan flow cytometer. Caspase activity was measured from the fluorescence derived from the covalent binding of inhibitor to active caspases in the cells.
Cell lysates and immunoblotting
BMMC were incubated overnight in complete RPMI medium, then washed in RPMI medium, and activated with 30 ng/ml IL-3 for the indicated times. Resting and activated cells were lysed in ice-cold 1% Brij 96-containing lysis buffer (50 mM TrisHCl, pH 7.2, 150 mM NaCl, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotinin, 10 g/ml antipain, 10 g/ml leupeptin) on ice for 15 min. Lysates were clarified by centrifugation at 4°C for 15 min at 13,000 rpm. Solubilized proteins were resolved by 7.5, 10, or 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels, transferred to nitrocellulose membranes, and blocked for 1 h by incubation with 3% Ig-free bovine serum albumin (Sigma Chemical Co.) for incubation with phospho-specific antibodies to selected signaling proteins (Akt, ERK1/2, p38, STAT5a/b, STAT3) or with 5% milk. Membranes were incubated for 2 h at room temperature with the indicated antibody, washed, and probed with HRP-conjugated goat anti-rabbit or goat anti-mouse IgG antibodies. Membranes were developed with SuperSignal substrate (Pierce) and exposed to film. The same blots were stripped with stripping buffer (62.5 mM Tris, pH 6.8, 100 mM 2-ME, 2% SDS) for 30 min at 60°C, washed, and reprobed with antibodies to the same signaling proteins to verify equal loading.
RESULTS
Lyn
Ϫ/Ϫ mice have increased numbers of peritoneal MC Peritoneal MC were isolated from the peritoneal cavities of WT and Lyn Ϫ/Ϫ mice. The Lyn Ϫ/Ϫ mice are typically somewhat smaller than WT mice and age-matched Lyn Ϫ/Ϫ animals, approximately 80% of the weight of WT mice (Table 1) . Therefore, data were obtained from three experiments using a total of 20 closely weight-matched mice from each group and from three experiments using a total of 13 age-matched mice from each group. Results, given in Table 1 , showed a smaller number of total cells (by approximately 30%) but a larger absolute number of MC (by more than 2.5-fold) in peritoneal lavages from Lyn Ϫ/Ϫ than from WT mice. As a result, MC are more than threefold greater as a percentage of total lavage cells in the Lyn Ϫ/Ϫ animals.
Increased expansion of BM cells from Lyn -/-mice
Culturing murine BM cells from WT and Lyn Ϫ/Ϫ mice in WEHI-3-conditioned medium gave rise to populations of granular cells that were more than 95% positive for the MC markers c-kit (Fig. 1A) , FcεRI (Fig. 1B) , and IL-3 (Fig. 1C) . In measurements made at any time between 5 and 8 weeks of culture, the levels of cell-surface FcεRI, c-kit, and IL-3R were always very similar between WT and Lyn Ϫ/Ϫ BMMC. However, total cell numbers were always higher for the Lyn Ϫ/Ϫ cultures ( Fig. 2A) .
To quantify rates of cell growth and to determine dependence on specific growth factors, cell cultures were initiated with equal numbers of BM cells (8ϫ10 6 ) suspended in media that contained increasing amounts of IL-3 or 10 ng/ml IL-3 plus 20 ng/ml SCF. The numbers of trypan blue-excluding cells were recorded at each weekly passage. Under all conditions tested, BM cells from Lyn Ϫ/Ϫ mice expanded more rapidly in culture than those obtained from WT mice (Fig. 2,  A-C) . As a result, cultures of Lyn Ϫ/Ϫ BM always generated dramatically more differentiated BMMC than WT cultures.
Lyn
Ϫ/Ϫ BMMC incorporate more thymidine and have a greater percentage of cells in the S-phase
To determine whether the increased numbers of BMMC cultured from the BM of Lyn Ϫ/Ϫ mice were a result of increased DNA synthesis or decreased cell death, thymidine incorporation, cell cycling, and apoptosis were measured in WT and Lyn Ϫ/Ϫ MC. DNA synthesis was measured in newly differentiated 5-to 6-week-old WT and Lyn Ϫ/Ϫ BMMC. Lyn Ϫ/Ϫ MC incorporated Peritoneal cells were isolated by lavage from age-matched (8-to 12-week-old) or weight-matched WT and Lyn -/-mice. Cells were stained with toluidine blue to distinguish granulated MC from other cells, and the whole population (except erythrocytes) was counted. Data are the means (ϮSEM) for total peritoneal cells and total MC obtained in three separate experiments with weight-matched mice (20 mice total) and in three separate experiments with age-matched mice (13 mice total). Mean values significantly different from WT levels are indicated: * P Ͻ 0.05; ** P Ͻ 0.01, Student's t-test. more thymidine than WT MC when incubated for 24 or 48 h in RPMI medium supplemented with their original WEHI-3-conditioned medium or with IL-3 (Fig. 3, A and B) . In medium supplemented with SCF alone, WT and Lyn Ϫ/Ϫ MC incorporated comparable amounts of thymidine at 24 h (Fig.  3A) , and Lyn Ϫ/Ϫ MC incorporated more thymidine at 48 h (Fig.  3B) . Conversely, in medium containing IL-3 and SCF, Lyn Ϫ/Ϫ BMMC incorporated more thymidine than WT BMMC at 24 h (Fig. 3A) , and both cell types incorporated comparable amounts of thymidine at 48 h (Fig. 3B) .
Even after 8 weeks in culture, Lyn Ϫ/Ϫ BMMC continued to expand in culture, and WT BMMC maintained the same numbers of cells (data not shown). We therefore measured thymidine incorporation in 8-week-old WT and Lyn Ϫ/Ϫ BMMC. In the older cultures, Lyn Ϫ/Ϫ BMMC incorporated more thymidine than WT cells when maintained in their original WEHI-3-conditioned medium and when transferred to RPMI medium plus IL-3 or SCF. Thymidine incorporation was not different between WT and Lyn Ϫ/Ϫ cells when IL-3 and SCF were present in combination (Fig. 3C) .
Withdrawal of FCS from the medium reduced total thymidine incorporation but provided the most dramatic demonstration of the greater proliferative capacity of the Lyn Ϫ/Ϫ BMMC (Fig. 3D) .
Cell-cycle analyses confirmed the faster growth rate of Lyn Ϫ/Ϫ BMMC. MC were cultured with the same growth factors used for thymidine incorporation studies, and the content of DNA was analyzed by flow cytometry following labeling of nuclei with PI. Lyn Ϫ/Ϫ MC had a significant increase in the proportion of cells in the S/G2/M phase of the cell cycle compared with WT BMMC when incubation was for 24 h in WEHI-3-conditioned RPMI medium (WT, 3Ϯ0.6%; Lyn Fig. 4B ). In RPMI supplemented with SCF alone, WT and Lyn Ϫ/Ϫ BMMC had comparable percentages of cells in the S/G2/M phase of the cell cycle at 24 h (WT, 21.5Ϯ1.5%; Lyn Ϫ/Ϫ , 27.2Ϯ0.8%; meanϮSEM, nϭ3; PϾ0.05; Fig. 4A ). However, there was a significant increase in the proportion of Lyn Ϫ/Ϫ BMMC versus WT BMMC in S/G2/M after stimulation with SCF at 48 h (WT, 23Ϯ1.2%; Lyn Ϫ/Ϫ , 35.7Ϯ1.5%; meanϮSEM, nϭ3; PϽ0.001; Fig. 4B ).
Caspase activation in response to growth-factor deprivation is delayed in Lyn Ϫ/Ϫ MC Rates of apoptosis in the absence and presence of growth factors were compared between WT and Lyn Ϫ/Ϫ MC by measuring the activation of caspases, a family of cysteine proteases that are central regulators of apoptosis.
In Figure 5A , WEHI-conditioned medium was replaced with RPMI medium alone, and the percentages of early (caspase ϩ /PI -; lower right quadrants) and late (caspase ϩ /PI ϩ ; upper right quandrants) apoptotic cells were quantified using flow cytometry. In the absence of growth factors, WT and Lyn Ϫ/Ϫ MC had equivalent numbers of early and late apoptotic cells after 24 h of growth-factor deprivation. However, a higher percentage of apoptotic WT MC was present at 48 h and at 72 h. In Figure 5B , WT and Lyn Ϫ/Ϫ MC were maintained in 30% WEHI-3-conditioned medium or transferred to RPMI medium with growth factors (10 ng/ml IL-3, 20 ng/ml SCF, or 10 ng/ml IL-3ϩ20 ng/ml SCF) for 24 and 48 h before performing the caspase activation assay. In this and six replicate experiments, the numbers of apoptotic cells in the presence of growth factors were essentially the same in WT and Lyn Ϫ/Ϫ MC. Thus, the greater numbers of Lyn Ϫ/Ϫ BMMC in the presence of growth factors result primarily from their more rapid proliferation and not from decreased apoptosis.
IL-3-induced phosphorylation of Akt and ERK1/2 is increased in Lyn-deficient MC
Activities of the survival kinases, Akt, and the proliferative MAPK family members, ERK1/2, stress-activated protein kinase (SAPK)/JNK, and p38 were measured by immunoblotting with antibodies to the phosphorylated (active) forms of these enzymes.
When cells were deprived of IL-3, Lyn Ϫ/Ϫ BMMC exhibit higher basal levels of phosphorylated Ser-473 (activated) Akt than WT BMMC (Fig. 6A) . Stimulation with IL-3 induced rapid phosphorylation of Akt in WT and Lyn Ϫ/Ϫ BMMC (Fig.  6A) . However, phosphorylation of Akt was prolonged in Lyn Ϫ/Ϫ BMMC (Fig. 6A) . Thus, increased Akt activity is likely to contribute to the enhanced survival of Lyn Ϫ/Ϫ BMMC. Phosphorylation of ERK1/2 was also more robust and prolonged in IL-3-stimulated Lyn Ϫ/Ϫ BMMC than in WT BMMC Ϫ/Ϫ BMMC were suspended at 0.5 ϫ 10 6 cells/ml in complete culture medium supplemented with 30% WEHI-3-conditioned medium, rIL-3 (10 ng/ml), or rSCF (20 ng/ml) for 24 h (A) or 48 h (B). Nuclei were labeled with PI, and the percentage of cells in (G0ϩG1), S, (G2ϩM) was determined by flow cytometry. Data are presented as mean Ϯ SEM for three independent experiments. Mean values significantly different from WT levels are indicated: *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001, Student's t-test. (Fig. 6B) . In contrast, no difference was observed in phosphorylation of SAPK/JNK (data not shown) or p38 (Fig. 6B ) between the two cell types. Thus, increased ERK1/2 activity is likely to contribute to the enhanced survival of Lyn Ϫ/Ϫ BMMC. As STATs are targets in IL-3-mediated signaling and are involved in cell proliferation, we also analyzed the levels and phosphorylation of STAT3 and STAT5 in resting and IL-3-stimulated BMMC. The anti-STAT3 antibodies recognize Stat3␣ (92 kDa) and its splice variant Stat3␤ (83 kDa), and the anti-STAT5 antibodies recognize STAT5a and STAT5b (ϳ90 kDa). The levels and intensities of phosphorylation of STAT3 were similar at all time points between WT and Lyn Ϫ/Ϫ BMMC (Fig. 6C) . The levels and phosphorylation of STAT5 were lower at all time points in Lyn Ϫ/Ϫ BMMC than in WT BMMC (Fig.   Fig. 5 . Caspase activation induced by growth-factor deprivation is delayed in Lyn Ϫ/Ϫ BMMC. Six-weekold WT and Lyn Ϫ/Ϫ BMMC obtained from BM cultures grown in 30% WEHI-3-conditioned medium were cultured at a density of 1 ϫ 10 6 cells/ml in the absence of growth factors for 24, 48, or 72 h (A) or in the presence of growth factors (B). Caspase activation was determined by fluorescence intensity derived from the caspase-bound inhibitor. Results shown are representative of seven independent experiments. Numbers (inset) report percent early apoptotic (caspase ϩ /PI -; lower right quadrants) and late (caspase ϩ /PI ϩ ; upper right quadrants) apoptotic. FITC, Fluorescein isothiocyanate. 6C). These data fail to implicate STATs in the hyperproliferation of IL-3-treated Lyn Ϫ/Ϫ BMMC.
DISCUSSION
We have used Lyn Ϫ/Ϫ BMMC to explore the role of the Src family member Lyn in the control of MC proliferation and survival. We report that Lyn Ϫ/Ϫ BM cells produce more BMMC than WT BM cells when incubation is in WEHI-3-conditioned medium and in RPMI medium with added IL-3 or IL-3 plus SCF. Furthermore, differentiated Lyn Ϫ/Ϫ BMMC proliferate faster than WT BMMC in medium containing IL-3 or IL-3 plus SCF. Older cultures of Lyn Ϫ/Ϫ BMMC also proliferate faster with SCF alone. The in vitro data are consistent with our measurements showing a substantial increase in the numbers of peritoneal MC in Lyn Ϫ/Ϫ mice in comparison with WT mice. Other investigators, using BM from mice in our colony, also observed higher rates of IL-3-mediated proliferation in Lyn MC in the presence of growth factors, we observed substantially more apoptosis induced by growth-factor withdrawal at 48 and 72 h in WT than Lyn Ϫ/Ϫ MC. Thus, Lyn Ϫ/Ϫ BMMC are also more resistant to apoptosis than their WT counterparts.
Our data differ from previous studies by Nishizumi and Yamamoto [10] , Kawakami et al. [11] , and O'Laughlin-Bunner et al. [12] . The Nishizumi and Kawakami groups [10, 11] reported that IL-3-stimulated Lyn Ϫ/Ϫ BM generates normal numbers of MC, and O'Laughlin-Bunner et al. [12] reported that SCF-induced proliferation of BM progenitors and BMMC is impaired in Lyn Ϫ/Ϫ cells. It is likely that our difference with Nishizumi and Yamamoto [10] and Kawakami et al. [11] can be explained by their predominant use of newly differentiated MC. Both groups worked with 4-week-old cultures, and we see greater differences in rates of cell expansion beyond that point. Furthermore, we performed survival assays using a caspase assay that gives a more accurate measure of apoptosis than trypan blue exclusion [11] . The difference between our data and those of O'Laughlin-Bunner et al. [12] , obtained using Lyn Ϫ/Ϫ mice from the same source [4] , is more puzzling. These investigators differentiated BMMC using IL-3-conditioned medium and then challenged the mature cells with high levels of SCF (100 ng/ml). Their phenotyping studies revealed greater levels of FcεRI and c-kit expression on the Lyn Ϫ/Ϫ BMMC, whereas we see no significant difference between Lyn Ϫ/Ϫ and WT cells in FcεRI, IL-3, and c-kit receptor expression. Similarly, Kawakami et al. [11] and Parravicini et al. [16] saw no difference in FcεRI expression between WT and Lyn Ϫ/Ϫ BMMC. Their proliferation studies revealed less SCF-induced thymidine incorporation in Lyn Ϫ/Ϫ BMMC but with very low levels of thymidine incorporation overall in comparison with our robust measures of thymidine incorporation [12] . Their cell-cycle studies revealed many fewer cycling cells in SCFstimulated cultures of Lyn Ϫ/Ϫ BMMC, again the opposite of our results. As Lyn has a multitude of positive and negative regulatory roles in cell physiology, it is possible that subtle differences in the age or health of the donor mice or in culture conditions could result in very different cell growth characteristics.
Cell growth and survival are regulated by a wide variety of signaling pathways, including JAKs and their targets, STATs, the PI-3K/Akt pathway, and the MAPK pathways. Based on the higher phosphorylation of Akt and ERK1/2 in Lyn Ϫ/Ϫ BMMC, our data implicate the prosurvival PI-3K/Akt pathway and the proproliferative ERK1/2 MAPK pathways in their greater proliferation and resistance to apoptosis in comparison with WT BMMC. Given the diverse roles for Lyn in cell regulation, it would not be surprising if other cell-signaling pathways involved in promoting cell-cycle progression and preventing apoptosis in response to IL-3 are also up-regulated in Lyndeficient cells. Conversely, we found no evidence for increased STAT3 or STAT5 phosphorylation in Lyn Ϫ/Ϫ BMMC. We also found no evidence for altered p38 or JNK activation between WT and Lyn Ϫ/Ϫ BMMC during a 24-h time course of growthfactor deprivation (data not shown) or after stimulation with IL-3. Thus, the absence of Lyn does not cause a nonspecific up-regulation of all pro-growth, antiapoptosis signaling pathways.
The mechanism(s) linking Lyn deficiency to increased MC proliferation remains to be defined. Several lines of evidence point to the Src homology 2-containing inositol phospholipid phosphatase (SHIP) as a possible, direct intermediate between the absence of Lyn and the occurrence of excess signaling through the PI-3K/Akt pathway and the ERK1/2 pathway. Thus, Lui et al. [17] identified SHIP as a crucial negative regulator of growth-factor receptor-mediated Akt activation and myeloid cell survival. They also showed that neutrophils and BMMC from SHIP Ϫ/Ϫ mice are less susceptible to apoptosis induced by growth-factor withdrawal [17] . Furthermore, increased ERK1/2 and Akt phosphorylation has been shown in SHIP Ϫ/Ϫ B cells [18, 19] , and SHIP Ϫ/Ϫ BMMC stimulated via the high-affinity IgE receptor [20] or with SCF [21] have increased and prolonged ERK1/2 phosphorylation. Finally, our own preliminary studies indicate that SHIP activity is reduced in Lyn Ϫ/Ϫ BMMC in comparison with WT BMMC (V. Hernandez-Hansen et al., manuscript in preparation). However, other factors including differences in the expression of cytokines could also contribute to the increased proliferation of Lyn Ϫ/Ϫ BMMC. Kawakami et al. [11] reported increased expression of IL-2 and tumor necrosis factor ␣ expression in Lyn Ϫ/Ϫ MC stimulated overnight with antigen. If IL-3 or SCF also induce higher levels of cytokine and growth-factor expression in Lyndeficient than in WT cells, the result could be greater signaling to cell survival and proliferation via pathways that are indirectly regulated by Lyn. Further studies are underway to distinguish between direct and indirect roles for Lyn in the negative regulation of IL-3 and SCF signaling to MC survival and proliferation.
Highlighting the critical role of Lyn in hematopoietic regulation, aged, Lyn-deficient mice develop a dramatic increase in myeloid progenitors, splenomegaly, disseminated monocyte/ macrophage tumors [3] , and B cell lymphomas (our unpublished results). Further studies on the Lyn-mediated, negative regulation of cytokine-mediated BMMC proliferation may reveal mechanisms that predispose Lyn-deficient mice to myeloid expansion and tumor development. New insight into human oncogenesis may in turn emerge from this improved understanding of the consequences of deregulated Lyn activity in hematopoietic cells.
